These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2295346)
1. Influence of a triphasic oral contraceptive preparation on plasma lipids and lipoproteins. Lussier-Cacan S; Nestruck AC; Arslanian H; Xhignesse M; Davignon J; Kafrissen ME; Chapdelaine A Fertil Steril; 1990 Jan; 53(1):28-34. PubMed ID: 2295346 [TBL] [Abstract][Full Text] [Related]
2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
3. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy. Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348 [TBL] [Abstract][Full Text] [Related]
4. Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations. Percival-Smith RK; Frohlich J; Jones WN; Abercrombie BA Contraception; 1988 Jul; 38(1):19-26. PubMed ID: 3168443 [TBL] [Abstract][Full Text] [Related]
5. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables. Phillips NR; Havel RJ; Kane JP Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694 [TBL] [Abstract][Full Text] [Related]
6. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related]
7. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins. Kruszon-Moran D; Burkman RT; Kimball AW; Bachorik PS; Gold EB Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983 [TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
9. The effect of triphasic oral contraceptives on plasma lipids and lipoproteins. Patsch W; Brown SA; Gotto AM; Young RL Am J Obstet Gynecol; 1989 Nov; 161(5):1396-401. PubMed ID: 2686455 [TBL] [Abstract][Full Text] [Related]
10. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women. Singh K; Ratnam SS Contraception; 1997 Aug; 56(2):77-83. PubMed ID: 9315415 [TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins. Voorhoof L; Rosseneu M; Caster H; De Keersgieter W J Endocrinol; 1986 Oct; 111(1):191-6. PubMed ID: 2946795 [TBL] [Abstract][Full Text] [Related]
13. The metabolic impact of oral contraceptives. Krauss RM; Burkman RT Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443 [TBL] [Abstract][Full Text] [Related]
14. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
15. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study. Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913 [TBL] [Abstract][Full Text] [Related]
16. Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives. Kuhl H; März W; Jung-Hoffmann C; Heidt F; Gross W Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):363-9. PubMed ID: 2142576 [TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress. Davis MC; Matthews KA Health Psychol; 1990; 9(6):717-36. PubMed ID: 2286182 [TBL] [Abstract][Full Text] [Related]
18. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Wynn V; Niththyananthan R Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):766-71. PubMed ID: 6801982 [TBL] [Abstract][Full Text] [Related]
19. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial. Notelovitz M; Feldman EB; Gillespy M; Gudat J Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1269-80. PubMed ID: 2655452 [TBL] [Abstract][Full Text] [Related]
20. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins. Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]